申请人:Katholieke Universiteit Leuven
公开号:US20140296272A1
公开(公告)日:2014-10-02
The present invention relates to a series of compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutic amount of such compounds, optionally combined with one or more other drugs having anti-viral activity.
本发明涉及一系列具有抗病毒活性的化合物,更具体地说是具有抑制HIV(人类免疫缺陷病毒)复制的性质。 本发明还涉及制备这种化合物的方法,以及在这些合成步骤中有用的新型中间体。 本发明还涉及包含有效量这种化合物作为活性成分的制药组合物。 本发明还涉及使用这种化合物作为药物或制造用于治疗患有病毒感染的动物,特别是HIV感染的药物。 本发明还涉及通过给予这种化合物的治疗量治疗动物的病毒感染的方法,可选择地与一个或多个具有抗病毒活性的其他药物结合使用。